ledipasvir

Details

Instance of

type of chemical entity

Subclass of

heterocyclic compound, carbocyclic compound

canonical SMILES

CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC

catalog

CAS COVID-19 Anti-Viral Candidate Compounds

chemical formula

C₄₉H₅₄F₂N₈O₆

has use

medication

isomeric SMILES

CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC

mass

888.413438

medical condition treated

hepatitis C

significant drug interaction

rosuvastatin, rosuvastatin

subject has role

xenobiotic-transporting ATPase inhibitor, antiviral agent, WHO essential medicines, bactericide, antiviral drug